Experiment: 5ID3

SOLUTION NMR

NMR Experiment
Experiment	Type	Sample Contents	Solvent	Ionic Strength	pH	Pressure	Temperature (K)	Spectrometer
1	2D 1H-15N TROSY	0.8 mM [100% 13C; 100% 15N; 85% 2H] MCU-dNTD, 27 mM Foscholine-14, 20 mM MES, 75 mM NaCl, 2 mM EDTA, 0.3 mM NaN3	95% H2O/5% D2O	100 mM	6.5	1 atm	23	Bruker AVANCE III 900
14	2D 1H-13C HSQC aliphatic	0.8 mM [100% 13C; 100% 15N] MCU-dNTD, 27 mM [100% 2H at acyl chain] Foscholine-14, 20 mM MES, 75 mM NaCl, 2 mM EDTA, 0.3 mM NaN3	95% H2O/5% D2O	100 mM	6.5	1 atm	23	Bruker AVANCE III 900
15	2D 1H-13C HSQC aliphatic	0.4 mM [100% 15N; 100% 2H] MCU-dNTD, 0.4 mM [15% 13C] MCU-dNTD, 27 mM [100% 2H at acyl chain] Foscholine-14, 20 mM MES, 75 mM NaCl, 2 mM EDTA, 0.3 mM NaN3	95% H2O/5% D2O	100 mM	6.5	1 atm	23	Bruker AVANCE III 900
2	3D tr-HNCA	0.8 mM [100% 13C; 100% 15N; 85% 2H] MCU-dNTD, 27 mM Foscholine-14, 20 mM MES, 75 mM NaCl, 2 mM EDTA, 0.3 mM NaN3	95% H2O/5% D2O	100 mM	6.5	1 atm	33	Bruker AVANCE II 600
3	3D tr-HN(CO)CA	0.8 mM [100% 13C; 100% 15N; 85% 2H] MCU-dNTD, 27 mM Foscholine-14, 20 mM MES, 75 mM NaCl, 2 mM EDTA, 0.3 mM NaN3	95% H2O/5% D2O	100 mM	6.5	1 atm	33	Bruker AVANCE II 600
4	3D tr-HN(CA)CO	0.8 mM [100% 13C; 100% 15N; 85% 2H] MCU-dNTD, 27 mM Foscholine-14, 20 mM MES, 75 mM NaCl, 2 mM EDTA, 0.3 mM NaN3	95% H2O/5% D2O	100 mM	6.5	1 atm	33	Bruker AVANCE II 600
5	3D tr-HNCO	0.8 mM [100% 13C; 100% 15N; 85% 2H] MCU-dNTD, 27 mM Foscholine-14, 20 mM MES, 75 mM NaCl, 2 mM EDTA, 0.3 mM NaN3	95% H2O/5% D2O	100 mM	6.5	1 atm	33	Bruker AVANCE II 600
6	3D tr-HN(CA)CB	0.8 mM [100% 13C; 100% 15N; 85% 2H] MCU-dNTD, 27 mM Foscholine-14, 20 mM MES, 75 mM NaCl, 2 mM EDTA, 0.3 mM NaN3	95% H2O/5% D2O	100 mM	6.5	1 atm	33	Bruker AVANCE II 600
7	3D 15N-15N HSQC-NOESY-TROSY	0.8 mM [100% 13C; 100% 15N; 85% 2H] MCU-dNTD, 27 mM Foscholine-14, 20 mM MES, 75 mM NaCl, 2 mM EDTA, 0.3 mM NaN3	95% H2O/5% D2O	100 mM	6.5	1 atm	23	Bruker AVANCE II 600
8	3D 1H-15N NOESY-TROSY	0.8 mM [100% 13C; 100% 15N] MCU-dNTD, 27 mM [100% 2H at acyl chain] Foscholine-14, 20 mM MES, 75 mM NaCl, 2 mM EDTA, 0.3 mM NaN3	95% H2O/5% D2O	100 mM	6.5	1 atm	23	Bruker AVANCE III 900
9	3D 1H-15N NOESY-TROSY	0.8 mM [100% 13C; 100% 15N] MCU-dNTD, 27 mM [100% 2H at acyl chain] Foscholine-14, 20 mM MES, 75 mM NaCl, 2 mM EDTA, 0.3 mM NaN3	95% H2O/5% D2O	100 mM	6.5	1 atm	33	Bruker AVANCE III 900
10	3D 1H-13C Methyl NOESY	0.8 mM [100% 13C; 100% 15N] MCU-dNTD, 27 mM [100% 2H at acyl chain] Foscholine-14, 20 mM MES, 75 mM NaCl, 2 mM EDTA, 0.3 mM NaN3	95% H2O/5% D2O	100 mM	6.5	1 atm	23	Bruker AVANCE III 900
11	3D 1H-13C Methyl NOESY	0.8 mM [100% 13C; 100% 15N] MCU-dNTD, 27 mM [100% 2H at acyl chain] Foscholine-14, 20 mM MES, 75 mM NaCl, 2 mM EDTA, 0.3 mM NaN3	95% H2O/5% D2O	100 mM	6.5	1 atm	33	Bruker AVANCE III 900
12	3D 1H-15N NOESY-TROSY	0.4 mM [100% 15N; 100% 2H] MCU-dNTD, 0.4 mM [15% 13C] MCU-dNTD, 27 mM [100% 2H at acyl chain] Foscholine-14, 20 mM MES, 75 mM NaCl, 2 mM EDTA, 0.3 mM NaN3	95% H2O/5% D2O	100 mM	6.5	1 atm	23	Bruker AVANCE III 900
13	3D 1H-15N NOESY-TROSY	0.4 mM [100% 15N; 100% 2H] MCU-dNTD, 0.4 mM [15% 13C] MCU-dNTD, 27 mM [100% 2H at acyl chain] Foscholine-14, 20 mM MES, 75 mM NaCl, 2 mM EDTA, 0.3 mM NaN3	95% H2O/5% D2O	100 mM	6.5	1 atm	33	Bruker AVANCE III 900

NMR Spectrometer Information
Spectrometer	Manufacturer	Model	Field Strength
1	Bruker	AVANCE II	600
2	Bruker	AVANCE III	900

NMR Refinement
Method	Details	Software
simulated annealing		XPLOR-NIH

NMR Ensemble Information
Conformer Selection Criteria	structures with the lowest energy
Conformers Calculated Total Number	150
Conformers Submitted Total Number	15
Representative Model	1 (lowest energy)

Computation: NMR Software
#	Classification	Version	Software Name	Author
1	processing	NMRPipe		Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax
2	chemical shift assignment	CcpNMR		CCPN
3	chemical shift assignment	XEASY		Bartels et al.
4	data analysis	NMRDraw		Delaglio, Grzesiek, Vuister, Zhu, Pfeifer and Bax
5	data analysis	TALOS		Cornilescu, Delaglio and Bax
6	structure calculation	XPLOR-NIH		Schwieters et al
7	refinement	XPLOR-NIH

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.